Gui-Qiang WANG, MD
Professor of Medicine
Chairman, Department of Infectious Diseases
Director, Center for Liver Diseases
Director, Clinical Trial Base for liver diseases.
Peking University First Hospital
Dr. Gui-Qiang Wang is now a professor and chairman in the department of infectious
diseases, and director of the center for liver diseases, Peking University First Hospital.
Dr. Wang has worked in the Pittsburgh University Medical Center as a postdoctoral
research associate and in the Scripps Research Institute as a visiting scholar from 1998 to
2001. His study interest includes the antiviral treatment of chronic hepatitis B and C, the
immunopathogenesis and immunotherapy of chronic HBV infection, and the mechanism of
immune tolerance in HBV infection, etc.
Dr. Wang has published more than 80 papers in the peer review journals such as Journal of
Experimental Medicine, Journal of Biology and Chemistry, and Journal of Viral Hepatitis,
and Chinese journals. He has take charge to constitute the National Diagnostic Criteria for
Hepatitis B, and as one of the experts draft out the Chinese guideline for the treatment of
Chronic hepatitis B. He is the editorial board member of Clinical Infectious Diseases and
Dr. Wang is a vice-President, Chinese Society of Physician for Infectious Diseases,
executive member and Secretary-General, Chinese Society for Infectious Diseases, deputy
director of National Group for viral hepatitis research, the National Committee, member for
the Hygienic Standard, the National Committee member for the diseases of natural focus,
and the National Committee for the Medical Evaluation, etc.